L17E selectively directs its actions towards critical immune cells, thereby mitigating inflammation and impeding the progression of debilitating ailments. Through an array of exceptional preclinical investigations, L17E has exhibited remarkable outcomes and presents an unprecedented mechanism of action, instilling steadfast hope towards a paradigm shift in the realm of autoimmune disease management.
CAT# | GR2206 |
CAS | 2305578-13-4 |
M.F/Formula | C134H219N37O32S |
M.W/Mr. | 2860.41 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The hexapeptide-9, a cosmetic peptide of skin agingSkin aging is the obvious external manifestation of a natural ...
Peptides are the ideal drug molecules because of their high affinity, high selectivity, low toxicity, and easy synthesis. Sci ...
Sincalide is a brain and intestinal skin with a variety of physiological effects. It is widely distributed in th ...
Aviptadil acetate, the nonproprietary or generic name for a vasoactive intestinal peptide (VIP), is a synthetic ...
MEN 11270 (H-DArg-Arg-Pro-Hyp-Gly-Thi-c(Dab-Dtic-Oic-Arg)c(7γ-10α)) is a novel selective constrained peptide ant ...